Profile
Siegmund Karasch is the founder of AdrenoMed AG.
He is currently a Member-Supervisory Board at Deutsche Biotech Innovativ AG since 2018.
Previously, he worked as Chief Executive & Operating Officer at InVivo BioTech Services GmbH.
He completed his undergraduate degree from Hochschule für Technik und Wirtschaft Berlin in 1993.
Siegmund Karasch active positions
| Companies | Position | Start |
|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Director/Board Member | 2018-07-04 |
Former positions of Siegmund Karasch
| Companies | Position | End |
|---|---|---|
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology Develops a drug to decrease mortality in severe sepsis | Founder | 2013-12-31 |
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Chief Executive Officer | - |
Training of Siegmund Karasch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Deutsche Biotech Innovativ AG
Deutsche Biotech Innovativ AG Financial ConglomeratesFinance Invests in companies which are involved in innovative business concepts and technologies | Finance |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology Develops a drug to decrease mortality in severe sepsis | Health Technology |
Hochschule für Technik und Wirtschaft Berlin
Hochschule für Technik und Wirtschaft Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
- Stock Market
- Insiders
- Siegmund Karasch
















